David Young - 16 Aug 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
16 Aug 2022
Net transactions value
$0
Form type
4
Filing time
23 Aug 2022, 16:30:49 UTC
Previous filing
09 Aug 2022
Next filing
03 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Gift $0 -9,250 -2.4% $0.000000 377,784 16 Aug 2022 Direct
holding PCSA Common Stock 573,568 16 Aug 2022 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 694,591 16 Aug 2022 By Family Entities
holding PCSA Common Stock 37,504 16 Aug 2022 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.